Status:
COMPLETED
Questionnaire Study Concerning Artificial Intelligence
Lead Sponsor:
Maastricht University Medical Center
Collaborating Sponsors:
Catharina Ziekenhuis Eindhoven
Conditions:
Gastro-Intestinal Disorders
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to investigate the knowledge, experience, and opinion on AI among gastroenterology (GI) patients, gastroenterologists, and GI-fellows, particularly concerning implementation and applic...
Detailed Description
In recent years, important developments have been made in the field of artificial intelligence (AI). These developments have led to the large-scale application of AI in our everyday lives and AI-resea...
Eligibility Criteria
Inclusion
- Gastrointestinal (GI) patients with an outpatient appointment in the gastroenterology department for an endoscopic procedure in the context of the Dutch national screening program, because of gastrointestinal symptoms, or because of follow-up of previously diagnosed bowel diseases (in one of the two participating hospitals);
- Gastroenterologists working in Dutch hospitals;
- Gastroenterology fellows working in Dutch hospitals;
- Minimal age of 18 years old.
Exclusion
- No appropriate understanding of the Dutch language;
- Not willing to sign informed consent;
- Objection to participate in medical scientific research, reported in the medical file.
Key Trial Info
Start Date :
April 8 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 12 2021
Estimated Enrollment :
457 Patients enrolled
Trial Details
Trial ID
NCT05214625
Start Date
April 8 2020
End Date
August 12 2021
Last Update
February 18 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Maastricht University Medical Center
Maastricht, Limburg, Netherlands, 6202AZ
2
Catharina Ziekenhuis Eindhoven
Eindhoven, North Brabant, Netherlands, 5623 EJ